Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature

Psoriatic patients present an increased risk for developing lymphoma, particularly cutaneous T-cell lymphoma (CTCL). To what degree psoriasis itself through chronic immune stimulation, or the immunosuppressive medications used for its treatment or comorbidities (obesity, diabetes mellitus, etc), or...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Achilleas Diakomopoulos, Maria Dalamaga, Evangelia Papadavid
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/033343e3ca1d44d395f970434442dc37
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:033343e3ca1d44d395f970434442dc37
record_format dspace
spelling oai:doaj.org-article:033343e3ca1d44d395f970434442dc372021-11-10T04:40:18ZUnderstanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature2589-936810.1016/j.metop.2021.100148https://doaj.org/article/033343e3ca1d44d395f970434442dc372021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589936821000724https://doaj.org/toc/2589-9368Psoriatic patients present an increased risk for developing lymphoma, particularly cutaneous T-cell lymphoma (CTCL). To what degree psoriasis itself through chronic immune stimulation, or the immunosuppressive medications used for its treatment or comorbidities (obesity, diabetes mellitus, etc), or lifestyle (smoking, alcohol, diet, etc) may play a role in the onset of MF is not yet clear. Psoriasis and Mycosis Fungoides (MF), the most common variant of CTCL, represent two distinct entities sharing common pathogenetic mechanisms and a wide spectrum of common clinical features associated with the abnormal activation of T-cells. The aim of this study is to explore the relationship between MF and psoriasis by presenting two cases with clinical and histopathologic features of both psoriasis and MF with a particular emphasis on the time of presentation of both disorders, the use of previous immunosuppressive drugs as well as the therapeutic management of patients. Biopsy of the cutaneous lesions before the introduction of biologics should be incorporated in clinical practice. Biopsy of the cutaneous lesion should also be performed in the case of appearance of psoriasiform lesions during biologic treatment for autoimmune disorders because this may represent an indolent form of MF. Psoriatic patients with poor or no-response to treatment should be examined thoroughly for MF using immunochemistry and, if necessary, molecular biology techniques. In concomitant MF and psoriasis, combination treatment may be beneficial for both entities. Finally, a large multicentric registry of MF patients who were treated for benign dermatoses (i.e. eczema, psoriasis) with classic immunosuppressive drugs and/or biologics is needed to collect data and further clarify the enigmatic relationship between psoriasis, MF and immunosuppressive treatment.Achilleas DiakomopoulosMaria DalamagaEvangelia PapadavidElsevierarticleAnti-TNFBiologicsCutaneous lymphomaImmunosuppressiveLymphomaMycosis fungoidesPhysiologyQP1-981BiochemistryQD415-436ENMetabolism Open, Vol 12, Iss , Pp 100148- (2021)
institution DOAJ
collection DOAJ
language EN
topic Anti-TNF
Biologics
Cutaneous lymphoma
Immunosuppressive
Lymphoma
Mycosis fungoides
Physiology
QP1-981
Biochemistry
QD415-436
spellingShingle Anti-TNF
Biologics
Cutaneous lymphoma
Immunosuppressive
Lymphoma
Mycosis fungoides
Physiology
QP1-981
Biochemistry
QD415-436
Achilleas Diakomopoulos
Maria Dalamaga
Evangelia Papadavid
Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature
description Psoriatic patients present an increased risk for developing lymphoma, particularly cutaneous T-cell lymphoma (CTCL). To what degree psoriasis itself through chronic immune stimulation, or the immunosuppressive medications used for its treatment or comorbidities (obesity, diabetes mellitus, etc), or lifestyle (smoking, alcohol, diet, etc) may play a role in the onset of MF is not yet clear. Psoriasis and Mycosis Fungoides (MF), the most common variant of CTCL, represent two distinct entities sharing common pathogenetic mechanisms and a wide spectrum of common clinical features associated with the abnormal activation of T-cells. The aim of this study is to explore the relationship between MF and psoriasis by presenting two cases with clinical and histopathologic features of both psoriasis and MF with a particular emphasis on the time of presentation of both disorders, the use of previous immunosuppressive drugs as well as the therapeutic management of patients. Biopsy of the cutaneous lesions before the introduction of biologics should be incorporated in clinical practice. Biopsy of the cutaneous lesion should also be performed in the case of appearance of psoriasiform lesions during biologic treatment for autoimmune disorders because this may represent an indolent form of MF. Psoriatic patients with poor or no-response to treatment should be examined thoroughly for MF using immunochemistry and, if necessary, molecular biology techniques. In concomitant MF and psoriasis, combination treatment may be beneficial for both entities. Finally, a large multicentric registry of MF patients who were treated for benign dermatoses (i.e. eczema, psoriasis) with classic immunosuppressive drugs and/or biologics is needed to collect data and further clarify the enigmatic relationship between psoriasis, MF and immunosuppressive treatment.
format article
author Achilleas Diakomopoulos
Maria Dalamaga
Evangelia Papadavid
author_facet Achilleas Diakomopoulos
Maria Dalamaga
Evangelia Papadavid
author_sort Achilleas Diakomopoulos
title Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature
title_short Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature
title_full Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature
title_fullStr Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature
title_full_unstemmed Understanding the enigmatic association between mycosis fungoides and psoriasis: Report of two cases and review of the literature
title_sort understanding the enigmatic association between mycosis fungoides and psoriasis: report of two cases and review of the literature
publisher Elsevier
publishDate 2021
url https://doaj.org/article/033343e3ca1d44d395f970434442dc37
work_keys_str_mv AT achilleasdiakomopoulos understandingtheenigmaticassociationbetweenmycosisfungoidesandpsoriasisreportoftwocasesandreviewoftheliterature
AT mariadalamaga understandingtheenigmaticassociationbetweenmycosisfungoidesandpsoriasisreportoftwocasesandreviewoftheliterature
AT evangeliapapadavid understandingtheenigmaticassociationbetweenmycosisfungoidesandpsoriasisreportoftwocasesandreviewoftheliterature
_version_ 1718440528860676096